|
1
|
Iida N, Dzutsev A, Stewart CA, Smith L,
Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S,
et al: Commensal bacteria control cancer response to therapy by
modulating the tumor microenvironment. Science. 342:967–970.
2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Boleij A, Hechenbleikner EM, Goodwin AC,
Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E,
Wick EC, et al: The Bacteroides fragilis toxin gene is prevalent in
the colon mucosa of colorectal cancer patients. Clin Infect Dis.
60:208–215. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qin J, Li R, Raes J, Arumugam M, Burgdorf
KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al:
MetaHIT Consortium: A human gut microbial gene catalogue
established by metagenomic sequencing. Nature. 464:59–65.
2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Blaser MJ: Who are we? Indigenous microbes
and the ecology of human diseases. EMBO Rep. 7:956–960.
2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bultman SJ: Emerging roles of the
microbiome in cancer. Carcinogenesis. 35:249–255. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Clemente JC, Ursell LK and Parfrey LW and
Knight R: The impact of the gut microbiota on human health: An
integrative view. Cell. 148:1258–1270. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Plottel CS and Blaser MJ: Microbiome and
malignancy. Cell Host Microbe. 10:324–335. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Petersen C and Round JL: Defining
dysbiosis and its influence on host immunity and disease. Cell
Microbiol. 16:1024–1033. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dietert RR and Dietert JM: The microbiome
and sustainable healthcare. Healthcare (Basel). 3:100–129.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Arslan N: Obesity, fatty liver disease and
intestinal microbiota. World J Gastroenterol. 20:16452–16463.
2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schwabe RF and Jobin C: The microbiome and
cancer. Nat Rev Cancer. 13:800–812. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Garrett WS: Cancer and the microbiota.
Science. 348:80–86. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Human Microbiome Project Consortium:
Structure, function and diversity of the healthy human microbiome.
Nature. 486:207–214. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Grice EA and Segre JA: The skin
microbiome. Nat Rev Microbiol. 9:244–253. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Suau A, Bonnet R, Sutren M, Godon JJ,
Gibson GR, Collins MD and Doré J: Direct analysis of genes encoding
16S rRNA from complex communities reveals many novel molecular
species within the human gut. Appl Environ Microbiol. 65:4799–4807.
1999.PubMed/NCBI
|
|
16
|
Savage DC: Microbial ecology of the
gastrointestinal tract. Annu Rev Microbiol. 31:107–133.
1977.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Neish AS: Microbes in gastrointestinal
health and disease. Gastroenterology. 136:65–80. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Goncharova GI, Dorofeĭchuk VG,
Smolianskaia AZ and Sokolova KIa: Microbial ecology of the
intestines in health and in pathology. Antibiot Khimioter.
34:462–466. 1989.(In Russian). PubMed/NCBI
|
|
19
|
Dominguez-Bello MG, Blaser MJ, Ley RE and
Knight R: Development of the human gastrointestinal microbiota and
insights from high-throughput sequencing. Gastroenterology.
140:1713–1719. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mulder IE, Schmidt B, Lewis M, Delday M,
Stokes CR, Bailey M, Aminov RI, Gill BP, Pluske JR, Mayer CD, et
al: Restricting microbial exposure in early life negates the immune
benefits associated with gut colonization in environments of high
microbial diversity. PLoS One. 6(e28279)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Claesson MJ, Cusack S, O'Sullivan O,
Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D,
Dinan T, Fitzgerald G, et al: Composition, variability, and
temporal stability of the intestinal microbiota of the elderly.
Proc Natl Acad Sci USA. 108((Suppl 1)): 4586–4591. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rajilić-Stojanović M, Heilig HGHJ,
Molenaar D, Kajander K, Surakka A, Smidt H and de Vos WM:
Development and application of the human intestinal tract chip, a
phylogenetic microarray: Analysis of universally conserved
phylotypes in the abundant microbiota of young and elderly adults.
Environ Microbiol. 11:1736–1751. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Turnbaugh PJ, Bäckhed F, Fulton L and
Gordon JI: Diet-induced obesity is linked to marked but reversible
alterations in the mouse distal gut microbiome. Cell Host Microbe.
3:213–223. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zwielehner J, Liszt K, Handschur M, Lassl
C, Lapin A and Haslberger AG: Combined PCR-DGGE fingerprinting and
quantitative-PCR indicates shifts in fecal population sizes and
diversity of Bacteroides, bifidobacteria and Clostridium cluster IV
in institutionalized elderly. Exp Gerontol. 44:440–446.
2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Eckburg PB, Bik EM, Bernstein CN, Purdom
E, Dethlefsen L, Sargent M, Gill SR, Nelson KE and Relman DA:
Diversity of the human intestinal microbial flora. Science.
308:1635–1638. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sommer F and Bäckhed F: The gut microbiota
- masters of host development and physiology. Nat Rev Microbiol.
11:227–238. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bäckhed F, Ley RE, Sonnenburg JL, Peterson
DA and Gordon JI: Host-bacterial mutualism in the human intestine.
Science. 307:1915–1920. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tlaskalová-Hogenová H, Stepánková R,
Hudcovic T, Tucková L, Cukrowska B, Lodinová-Zádníková R, Kozáková
H, Rossmann P, Bártová J, Sokol D, et al: Commensal bacteria
(normal microflora), mucosal immunity and chronic inflammatory and
autoimmune diseases. Immunol Lett. 93:97–108. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang L, Zhao N, Zhang F, Yue W and Liang
M: Effect of taurine on leucocyte function. Eur J Pharmacol.
616:275–280. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
O'Hara AM and Shanahan F: The gut flora as
a forgotten organ. EMBO Rep. 7:688–693. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Proctor LM: The human microbiome project
in 2011 and beyond. Cell Host Microbe. 10:287–291. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Weisburger JH, Reddy BS, Narisawa T and
Wynder EL: Germ-free status and colon tumor induction by
N-methyl-N'-nitro-N-nitrosoguanidine. Proc Soc Exp Biol Med.
148:1119–1121. 1975.PubMed/NCBI
|
|
33
|
Peterson DA, Frank DN, Pace NR and Gordon
JI: Metagenomic approaches for defining the pathogenesis of
inflammatory bowel diseases. Cell Host Microbe. 3:417–427.
2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Walsh CJ, Guinane CM, O'Toole PW and
Cotter PD: Beneficial modulation of the gut microbiota. FEBS Lett.
588:4120–4130. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kamada N and Núñez G: Role of the gut
microbiota in the development and function of lymphoid cells. J
Immunol. 190:1389–1395. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Blaser MJ and Falkow S: What are the
consequences of the disappearing human microbiota? Nat Rev
Microbiol. 7:887–894. 2009.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hooper LV and Macpherson AJ: Immune
adaptations that maintain homeostasis with the intestinal
microbiota. Nat Rev Immunol. 10:159–169. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Palmer C, Bik EM, DiGiulio DB, Relman DA
and Brown PO: Development of the human infant intestinal
microbiota. PLoS Biol. 5(e177)2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Neish AS: Mucosal immunity the microbiome.
Ann Am Thorac Soc. 11((Suppl 1)): S28–S32. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lozupone CA, Stombaugh JI, Gordon JI,
Jansson JK and Knight R: Diversity, stability and resilience of the
human gut microbiota. Nature. 489:220–230. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Morgan XC and Huttenhower C: Chapter 12:
Human microbiome analysis. PLOS Comput Biol.
8(e1002808)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hooper LV, Littman DR and Macpherson AJ:
Interactions between the microbiota and the immune system. Science.
336:1268–1273. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Khoruts A, Dicksved J, Jansson JK and
Sadowsky MJ: Changes in the composition of the human fecal
microbiome after bacteriotherapy for recurrent Clostridium
difficile-associated diarrhea. J Clin Gastroenterol. 44:354–360.
2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Reid G, Younes JA, Van der Mei HC, Gloor
GB, Knight R and Busscher HJ: Microbiota restoration: Natural and
supplemented recovery of human microbial communities. Nat Rev
Microbiol. 9:27–38. 2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Swiatczak B, Rescigno M and Cohen IR:
Systemic features of immune recognition in the gut. Microbes
Infect. 13:983–991. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Arthur JC and Jobin C: The struggle within
Microbial influences on colorectal cancer. Inflamm Bowel Dis.
17:396–409. 2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ley RE, Bäckhed F, Turnbaugh P, Lozupone
CA, Knight RD and Gordon JI: Obesity alters gut microbial ecology.
Proc Natl Acad Sci USA. 102:11070–11075. 2005.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ivanov II, Frutos R de L, Manel N,
Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB and Littman DR:
Specific microbiota direct the differentiation of IL-17-producing
T-helper cells in the mucosa of the small intestine. Cell Host
Microbe. 4:337–349. 2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Johansson MEV, Jakobsson HE,
Holmén-Larsson J, Schütte A, Ermund A, Rodríguez-Piñeiro AM, Arike
L, Wising C, Svensson F, Bäckhed F, et al: Normalization of host
intestinal mucus layers requires long-term microbial colonization.
Cell Host Microbe. 18:582–592. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Spiljar M, Merkler D and Trajkovski M: The
immune system bridges the gut microbiota with systemic energy
homeostasis: focus on TLRs, mucosal barrier, and SCFAs. Front
Immunol. 8(1353)2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Round JL and Mazmanian SK: Inducible
Foxp3+ regulatory T-cell development by a commensal bacterium of
the intestinal microbiota. Proc Natl Acad Sci USA. 107:12204–12209.
2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hepworth MR, Monticelli LA, Fung TC,
Ziegler CG, Grunberg S, Sinha R, Mantegazza AR, Ma HL, Crawford A,
Angelosanto JM, et al: Innate lymphoid cells regulate CD4+ T-cell
responses to intestinal commensal bacteria. Nature. 498:113–117.
2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Gaboriau-Routhiau V, Rakotobe S, Lécuyer
E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M,
Brandi G, et al: The key role of segmented filamentous bacteria in
the coordinated maturation of gut helper T cell responses.
Immunity. 31:677–689. 2009.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Garland CD, Lee A and Dickson MR:
Segmented filamentous bacteria in the rodent small intestine: Their
colonization of growing animals and possible role in host
resistance to Salmonella. Microb Ecol. 8:181–190. 1982.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yang Y, Torchinsky MB, Gobert M, Xiong H,
Xu M, Linehan JL, Alonzo F, Ng C, Chen A, Lin X, et al: Focused
specificity of intestinal TH17 cells towards commensal bacterial
antigens. Nature. 510:152–156. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Schnupf P, Gaboriau-Routhiau V and
Cerf-Bensussan N: Host interactions with segmented filamentous
bacteria: An unusual trade-off that drives the post-natal
maturation of the gut immune system. Semin Immunol. 25:342–351.
2013.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wu HJ, Ivanov II, Darce J, Hattori K,
Shima T, Umesaki Y, Littman DR, Benoist C and Mathis D:
Gut-residing segmented filamentous bacteria drive autoimmune
arthritis via T helper 17 cells. Immunity. 32:815–827.
2010.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Song X, Gao H, Lin Y, Yao Y, Zhu S, Wang
J, Liu Y, Yao X, Meng G, Shen N, et al: Alterations in the
microbiota drive interleukin-17C production from intestinal
epithelial cells to promote tumorigenesis. Immunity. 40:140–152.
2014.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Xu M, Pokrovskii M, Ding Y, Yi R, Au C,
Harrison OJ, Galan C, Belkaid Y, Bonneau R and Littman DR:
c-MAF-dependent regulatory T cells mediate immunological tolerance
to a gut pathobiont. Nature. 554:373–377. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Kamada N and Núñez G: Regulation of the
immune system by the resident intestinal bacteria.
Gastroenterology. 146:1477–1488. 2014.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Martín R, Miquel S, Chain F, Natividad JM,
Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, et al:
Faecalibacterium prausnitzii prevents physiological damages in a
chronic low-grade inflammation murine model. BMC Microbiol.
15(67)2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Honda K and Littman DR: The microbiota in
adaptive immune homeostasis and disease. Nature. 535:75–84.
2016.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Naik S, Bouladoux N, Wilhelm C, Molloy MJ,
Salcedo R, Kastenmuller W, Deming C, Quinones M, Koo L, Conlan S,
et al: Compartmentalized control of skin immunity by resident
commensals. Science. 337:1115–1119. 2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Naik S, Bouladoux N, Linehan JL, Han SJ,
Harrison OJ, Wilhelm C, Conlan S, Himmelfarb S, Byrd AL, Deming C,
et al: Commensal-dendritic-cell interaction specifies a unique
protective skin immune signature. Nature. 520:104–108.
2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Hajishengallis G, Liang S, Payne MA,
Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL,
Lambris JD, et al: Low-abundance biofilm species orchestrates
inflammatory periodontal disease through the commensal microbiota
and complement. Cell Host Microbe. 10:497–506. 2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Hajishengallis G and Lamont RJ: Breaking
bad: Manipulation of the host response by Porphyromonas gingivalis.
Eur J Immunol. 44:328–338. 2014.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Abt MC, Osborne LC, Monticelli LA, Doering
TA, Alenghat T, Sonnenberg GF, Paley MA, Antenus M, Williams KL,
Erikson J, et al: Commensal bacteria calibrate the activation
threshold of innate antiviral immunity. Immunity. 37:158–170.
2012.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Belkaid Y and Naik S: Compartmentalized
and systemic control of tissue immunity by commensals. Nat Immunol.
14:646–653. 2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Ichinohe T, Pang IK, Kumamoto Y, Peaper
DR, Ho JH, Murray TS and Iwasaki A: Microbiota regulates immune
defense against respiratory tract influenza A virus infection. Proc
Natl Acad Sci USA. 108:5354–5359. 2011.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Chervonsky AV: Microbiota autoimmunity.
Cold Spring Harb Perspect Biol. 5(a007294)2013.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Lee YK, Menezes JS, Umesaki Y and
Mazmanian SK: Proinflammatory T-cell responses to gut microbiota
promote experimental autoimmune encephalomyelitis. Proc Natl Acad
Sci USA. 108((Suppl 1)): 4615–4622. 2011.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Kim YG, Udayanga KGS, Totsuka N, Weinberg
JB, Núñez G and Shibuya A: Gut dysbiosis promotes M2 macrophage
polarization and allergic airway inflammation via fungi-induced
PGE2. Cell Host Microbe. 15:95–102. 2014.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Mangeney M, Pothlichet J, Renard M, Ducos
B and Heidmann T: Endogenous retrovirus expression is required for
murine melanoma tumor growth in vivo. Cancer Res. 65:2588–2591.
2005.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Vaishnava S, Behrendt CL, Ismail AS,
Eckmann L and Hooper LV: Paneth cells directly sense gut commensals
and maintain homeostasis at the intestinal host-microbial
interface. Proc Natl Acad Sci USA. 105:20858–20863. 2008.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Ménard S, Cerf-Bensussan N and Heyman M:
Multiple facets of intestinal permeability and epithelial handling
of dietary antigens. Mucosal Immunol. 3:247–259. 2010.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Mortha A, Chudnovskiy A, Hashimoto D,
Bogunovic M, Spencer SP, Belkaid Y and Merad M:
Microbiota-dependent crosstalk between macrophages and ILC3
promotes intestinal homeostasis. Science.
343(1249288)2014.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Rescigno M: Intestinal microbiota and its
effects on the immune system. Cell Microbiol. 16:1004–1013.
2014.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics 2014. CA Cancer J Clin. 64:104–117.
2014.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Shen H, Yang J, Huang Q, Jiang MJ, Tan YN,
Fu JF, Zhu LZ, Fang XF and Yuan Y: Different treatment strategies
and molecular features between right-sided and left-sided colon
cancers. World J Gastroenterol. 21:6470–6478. 2015.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tamas K, Walenkamp AM, de Vries EG, van
Vugt MA, Beets-Tan RG, van Etten B, de Groot DJ and Hospers GA:
Rectal and colon cancer: Not just a different anatomic site. Cancer
Treat Rev. 41:671–679. 2015.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Carethers JM and Jung BH: Genetics and
genetic biomarkers in sporadic colorectal Cancer. Gastroenterology.
149:1177–1190.e3. 2015.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Watson AJ and Collins PD: Colon cancer A
civilization disorder. Dig Dis. 29:222–228. 2011.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Starnes CO: Coley's toxins in perspective.
Nature. 357:11–12. 1992.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Hoption Cann SA, van Netten JP and van
Netten C: Dr William Coley and tumour regression: A place in
history or in the future. Postgrad Med J. 79:672–680.
2003.PubMed/NCBI
|
|
85
|
Grange JM, Bottasso O, Stanford CA and
Stanford JL: The use of mycobacterial adjuvant-based agents for
immunotherapy of cancer. Vaccine. 26:4984–4990. 2008.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Reddy BS, Mastromarino A and Wynder EL:
Further leads on metabolic epidemiology of large bowel cancer.
Cancer Res. 35:3403–3406. 1975.PubMed/NCBI
|
|
87
|
Schreiber H, Nettesheim P, Lijinsky W,
Richter CB and Walburg HE Jr: Induction of lung cancer in germfree,
specific-pathogen-free, and infected rats by
N-nitrosoheptamethyleneimine: Enhancement by respiratory infection.
J Natl Cancer Inst. 49:1107–1114. 1972.PubMed/NCBI
|
|
88
|
Dapito DH, Mencin A, Gwak GY, Pradere JP,
Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A,
Bataller R, et al: Promotion of hepatocellular carcinoma by the
intestinal microbiota and TLR4. Cancer Cell. 21:504–516.
2012.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Reddy BS and Watanabe K: Effect of
intestinal microflora on 2,2'-dimethyl-4-aminobiphenyl-induced
carcinogenesis in F344 rats. J Natl Cancer Inst. 61:1269–1271.
1978.PubMed/NCBI
|
|
90
|
Uronis JM, Mühlbauer M, Herfarth HH,
Rubinas TC, Jones GS and Jobin C: Modulation of the intestinal
microbiota alters colitis-associated colorectal cancer
susceptibility. PLoS One. 4(e6026)2009.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Lofgren JL, Whary MT, Ge Z, Muthupalani S,
Taylor NS, Mobley M, Potter A, Varro A, Eibach D, Suerbaum S, et
al: Lack of commensal flora in Helicobacter pylori-infected INS-GAS
mice reduces gastritis and delays intraepithelial neoplasia.
Gastroenterology. 140:210–220. 2011.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Vannucci L, Stepankova R, Kozakova H,
Fiserova A, Rossmann P and Tlaskalova-Hogenova H: Colorectal
carcinogenesis in germ-free and conventionally reared rats:
Different intestinal environments affect the systemic immunity. Int
J Oncol. 32:609–617. 2008.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Dove WF, Clipson L, Gould KA, Luongo C,
Marshall DJ, Moser AR, Newton MA and Jacoby RF: Intestinal
neoplasia in the ApcMin mouse: Independence from the microbial and
natural killer (beige locus) status. Cancer Res. 57:812–814.
1997.PubMed/NCBI
|
|
94
|
Yoshimoto S, Loo TM, Atarashi K, Kanda H,
Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, et
al: Obesity-induced gut microbial metabolite promotes liver cancer
through senescence secretome. Nature. 499:97–101. 2013.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Chen GY, Shaw MH, Redondo G and Núñez G:
The innate immune receptor Nod1 protects the intestine from
inflammation-induced tumorigenesis. Cancer Res. 68:10060–10067.
2008.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Grivennikov SI, Wang K, Mucida D, Stewart
CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung
KE, et al: Adenoma-linked barrier defects and microbial products
drive IL-23/IL-17-mediated tumour growth. Nature. 491:254–258.
2012.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Klimesova K, Kverka M, Zakostelska Z,
Hudcovic T, Hrncir T, Stepankova R, Rossmann P, Ridl J, Kostovcik
M, Mrazek J, et al: Altered gut microbiota promotes
colitis-associated cancer in IL-1 receptor-associated kinase
M-deficient mice. Inflamm Bowel Dis. 19:1266–1277. 2013.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Garrett WS, Punit S, Gallini CA, Michaud
M, Zhang D, Sigrist KS, Lord GM, Glickman JN and Glimcher LH:
Colitis-associated colorectal cancer driven by T-bet deficiency in
dendritic cells. Cancer Cell. 16:208–219. 2009.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Kado S, Uchida K, Funabashi H, Iwata S,
Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M and Morotomi M:
Intestinal microflora are necessary for development of spontaneous
adenocarcinoma of the large intestine in T-cell receptor beta chain
and p53 double-knockout mice. Cancer Res. 61:2395–2398.
2001.PubMed/NCBI
|
|
100
|
Engle SJ, Ormsby I, Pawlowski S, Boivin
GP, Croft J, Balish E and Doetschman T: Elimination of colon cancer
in germ-free transforming growth factor beta 1-deficient mice.
Cancer Res. 62:6362–6366. 2002.PubMed/NCBI
|
|
101
|
Erdman SE, Poutahidis T, Tomczak M, Rogers
AB, Cormier K, Plank B, Horwitz BH and Fox JG: CD4+ CD25+
regulatory T lymphocytes inhibit microbially induced colon cancer
in Rag2-deficient mice. Am J Pathol. 162:691–702. 2003.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Garrett WS, Lord GM, Punit S,
Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN and Glimcher LH:
Communicable ulcerative colitis induced by T-bet deficiency in the
innate immune system. Cell. 131:33–45. 2007.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Garrett WS, Gallini CA, Yatsunenko T,
Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L,
Glickman JN, et al: Enterobacteriaceae act in concert with the gut
microbiota to induce spontaneous and maternally transmitted
colitis. Cell Host Microbe. 8:292–300. 2010.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Balish E and Warner T: Enterococcus
faecalis induces inflammatory bowel disease in interleukin-10
knockout mice. Am J Pathol. 160:2253–2257. 2002.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Zhan Y, Chen PJ, Sadler WD, Wang F, Poe S,
Núñez G, Eaton KA and Chen GY: Gut microbiota protects against
gastrointestinal tumorigenesis caused by epithelial injury. Cancer
Res. 73:7199–7210. 2013.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Hussain SP, Hofseth LJ and Harris CC:
Radical causes of cancer. Nat Rev Cancer. 3:276–285.
2003.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Maddocks ODK, Short AJ, Donnenberg MS,
Bader S and Harrison DJ: Attaching and effacing Escherichia coli
downregulate DNA mismatch repair protein in vitro and are
associated with colorectal adenocarcinomas in humans. PLoS One.
4(e5517)2009.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Salcedo R, Worschech A, Cardone M, Jones
Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O'hUigin C, et al:
MyD88-mediated signaling prevents development of adenocarcinomas of
the colon: Role of interleukin 18. J Exp Med. 207:1625–1636.
2010.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Saleh M and Trinchieri G: Innate immune
mechanisms of colitis and colitis-associated colorectal cancer. Nat
Rev Immunol. 11:9–20. 2011.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Rakoff-Nahoum S, Paglino J,
Eslami-Varzaneh F, Edberg S and Medzhitov R: Recognition of
commensal microflora by toll-like receptors is required for
intestinal homeostasis. Cell. 118:229–241. 2004.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Sears CL and Garrett WS: Microbes,
microbiota, and colon cancer. Cell Host Microbe. 15:317–328.
2014.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Eslick GD: Helicobacter pylori infection
causes gastric cancer? A review of the epidemiological,
meta-analytic, and experimental evidence. World J Gastroenterol.
12:2991–2999. 2006.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Buti L, Spooner E, van der Veen AG,
Rappuoli R, Covacci A and Ploegh HL: Helicobacter pylori
cytotoxin-associated gene A (CagA) subverts the
apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor
pathway of the host. Proc Natl Acad Sci USA. 108:9238–9243.
2011.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Wroblewski LE, Peek RM Jr and Wilson KT:
Helicobacter pylori and gastric cancer: Factors that modulate
disease risk. Clin Microbiol Rev. 23:713–739. 2010.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Marshall BJ and Warren JR: Unidentified
curved bacilli in the stomach of patients with gastritis and peptic
ulceration. Lancet. 1:1311–1315. 1984.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022.
2009.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Geis AL, Fan H, Wu X, Wu S, Huso DL, Wolfe
JL, Sears CL, Pardoll DM and Housseau F: Regulatory T-cell response
to enterotoxigenic Bacteroides fragilis colonization triggers
IL17-dependent colon carcinogenesis. Cancer Discov. 5:1098–1109.
2015.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Kim SC, Tonkonogy SL, Albright CA, Tsang
J, Balish EJ, Braun J, Huycke MM and Sartor RB: Variable phenotypes
of enterocolitis in interleukin 10-deficient mice monoassociated
with two different commensal bacteria. Gastroenterology.
128:891–906. 2005.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Wang X, Yang Y, Moore DR, Nimmo SL,
Lightfoot SA and Huycke MM: 4-Hydroxy-2-nonenal mediates
genotoxicity and bystander effects caused by Enterococcus
faecalis-infected macrophages. Gastroenterology. 142:543–551, e7.
2012.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Kostic AD, Chun E, Robertson L, Glickman
JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold
GL, et al: Fusobacterium nucleatum potentiates intestinal
tumorigenesis and modulates the tumor-immune microenvironment. Cell
Host Microbe. 14:207–215. 2013.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Abed J, Emgård JEM, Zamir G, Faroja M,
Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, et al:
Fap2 mediates fusobacterium nucleatum colorectal adenocarcinoma
enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host
Microbe. 20:215–225. 2016.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Signat B, Roques C, Poulet P and Duffaut
D: Fusobacterium nucleatum in periodontal health and disease. Curr
Issues Mol Biol. 13:25–36. 2011.PubMed/NCBI
|
|
123
|
Strauss J, Kaplan GG, Beck PL, Rioux K,
Panaccione R, Devinney R, Lynch T and Allen-Vercoe E: Invasive
potential of gut mucosa-derived Fusobacterium nucleatum positively
correlates with IBD status of the host. Inflamm Bowel Dis.
17:1971–1978. 2011.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Sobhani I, Tap J, Roudot-Thoraval F,
Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J and
Furet JP: Microbial dysbiosis in colorectal cancer (CRC) patients.
PLoS One. 6(e16393)2011.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Castellarin M, Warren RL, Freeman JD,
Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P,
Allen-Vercoe E, Moore RA, et al: Fusobacterium nucleatum infection
is prevalent in human colorectal carcinoma. Genome Res. 22:299–306.
2012.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Rubinstein MR, Wang X, Liu W, Hao Y, Cai G
and Han YW: Fusobacterium nucleatum promotes colorectal
carcinogenesis by modulating E-cadherin/β-catenin signaling via its
FadA adhesin. Cell Host Microbe. 14:195–206. 2013.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Gur C, Ibrahim Y, Isaacson B, Yamin R,
Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N,
Coppenhagen-Glazer S, et al: Binding of the Fap2 protein of
Fusobacterium nucleatum to human inhibitory receptor TIGIT protects
tumors from immune cell attack. Immunity. 42:344–355.
2015.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Liu H, Redline RW and Han YW:
Fusobacterium nucleatum induces fetal death in mice via stimulation
of TLR4-mediated placental inflammatory response. J Immunol.
179:2501–2508. 2007.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Lee P and Tan KS: Fusobacterium nucleatum
activates the immune response through retinoic acid-inducible gene
I. J Dent Res. 93:162–168. 2014.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Chaushu S, Wilensky A, Gur C, Shapira L,
Elboim M, Halftek G, Polak D, Achdout H, Bachrach G and Mandelboim
O: Direct recognition of Fusobacterium nucleatum by the NK cell
natural cytotoxicity receptor NKp46 aggravates periodontal disease.
PLoS Pathog. 8(e1002601)2012.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Huycke MM and Gaskins HR: Commensal
bacteria, redox stress, and colorectal cancer Mechanisms and
models. Exp Biol Med (Maywood). 229:586–597. 2004.PubMed/NCBI
|
|
132
|
Rooks MG and Garrett WS: Bacteria, food,
and cancer. F1000 Biol Rep 3. 12:2011.PubMed/NCBI View
Article : Google Scholar
|
|
133
|
Goodwin AC, Destefano Shields CE, Wu S,
Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S,
Woster PM, Sears CL, et al: Polyamine catabolism contributes to
enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.
Proc Natl Acad Sci USA. 108:15354–15359. 2011.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Arthur JC, Perez-Chanona E, Mühlbauer M,
Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B,
Rogers AB, et al: Intestinal inflammation targets cancer-inducing
activity of the microbiota. Science. 338:120–123. 2012.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Cougnoux A, Dalmasso G, Martinez R, Buc E,
Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M,
et al: Bacterial genotoxin colibactin promotes colon tumour growth
by inducing a senescence-associated secretory phenotype. Gut.
63:1932–1942. 2014.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Mangerich A, Knutson CG, Parry NM,
Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL, Mobley M, Ge
Z, et al: Infection-induced colitis in mice causes dynamic and
tissue-specific changes in stress response and DNA damage leading
to colon cancer. Proc Natl Acad Sci USA. 109:E1820–E1829.
2012.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Wang X, Allen TD, May RJ, Lightfoot S,
Houchen CW and Huycke MM: Enterococcus faecalis induces aneuploidy
and tetraploidy in colonic epithelial cells through a bystander
effect. Cancer Res. 68:9909–9917. 2008.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Buc E, Dubois D, Sauvanet P, Raisch J,
Delmas J, Darfeuille-Michaud A, Pezet D and Bonnet R: High
prevalence of mucosa-associated Ecoli producing cyclomodulin and
genotoxin in colon cancer. PLoS One. 8(e56964)2013.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Cuevas-Ramos G, Petit CR, Marcq I, Boury
M, Oswald E and Nougayrède JP: Escherichia coli induces DNA damage
in vivo and triggers genomic instability in mammalian cells. Proc
Natl Acad Sci USA. 107:11537–11542. 2010.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Devkota S, Wang Y, Musch MW, Leone V,
Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B and Chang
EB: Dietary-fat-induced taurocholic acid promotes pathobiont
expansion and colitis in IL10-/- mice. Nature. 487:104–108.
2012.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Maggio-Price L, Treuting P, Zeng W, Tsang
M, Bielefeldt-Ohmann H and Iritani BM: Helicobacter infection is
required for inflammation and colon cancer in SMAD3-deficient mice.
Cancer Res. 66:828–838. 2006.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Chu F-F, Esworthy RS, Chu PG, Longmate JA,
Huycke MM, Wilczynski S and Doroshow JH: Bacteria-induced
intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes.
Cancer Res. 64:962–968. 2004.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Ellmerich S, Schöller M, Duranton B, Gossé
F, Galluser M, Klein JP and Raul F: Promotion of intestinal
carcinogenesis by Streptococcus bovis. Carcinogenesis. 21:753–756.
2000.PubMed/NCBI
|
|
144
|
Sheflin AM, Whitney AK and Weir TL:
Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep.
16(406)2014.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Jobin C: Colorectal cancer: CRC - all
about microbial products and barrier function? Nat Rev
Gastroenterol Hepatol. 9:694–696. 2012.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Rao VP, Poutahidis T, Ge Z, Nambiar PR,
Boussahmain C, Wang YY, Horwitz BH, Fox JG and Erdman SE: Innate
immune inflammatory response against enteric bacteria Helicobacter
hepaticus induces mammary adenocarcinoma in mice. Cancer Res.
66:7395–7400. 2006.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Reddy BS, Weisburger JH, Narisawa T and
Wynder EL: Colon carcinogenesis in germ-free rats with
1,2-dimethylhydrazine and N-methyl-n'-nitro-N-nitrosoguanidine.
Cancer Res. 34:2368–2372. 1974.PubMed/NCBI
|
|
148
|
Reddy BS, Narisawa T, Wright P, Vukusich
D, Weisburger JH and Wynder EL: Colon carcinogenesis with
azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res.
35:287–290. 1975.PubMed/NCBI
|
|
149
|
Winter SE, Lopez CA and Bäumler AJ: The
dynamics of gut-associated microbial communities during
inflammation. EMBO Rep. 14:319–327. 2013.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Allen IC, TeKippe EM, Woodford RM, Uronis
JM, Holl EK, Rogers AB, Herfarth HH, Jobin C and Ting JP: The NLRP3
inflammasome functions as a negative regulator of tumorigenesis
during colitis-associated cancer. J Exp Med. 207:1045–1056.
2010.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Elinav E, Strowig T, Kau AL, Henao-Mejia
J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon
JI, et al: NLRP6 inflammasome regulates colonic microbial ecology
and risk for colitis. Cell. 145:745–757. 2011.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Couturier-Maillard A, Secher T, Rehman A,
Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T,
Bressenot A, Delanoye-Crespin A, et al: NOD2-mediated dysbiosis
predisposes mice to transmissible colitis and colorectal cancer. J
Clin Invest. 123:700–711. 2013.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Hu B, Elinav E, Huber S, Strowig T, Hao L,
Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, et
al: Microbiota-induced activation of epithelial IL-6 signaling
links inflammasome-driven inflammation with transmissible cancer.
Proc Natl Acad Sci USA. 110:9862–9867. 2013.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Velcich A, Yang W, Heyer J, Fragale A,
Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K and
Augenlicht L: Colorectal cancer in mice genetically deficient in
the mucin Muc2. Science. 295:1726–1729. 2002.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Ochi A, Nguyen AH, Bedrosian AS, Mushlin
HM, Zarbakhsh S, Barilla R, Zambirinis CP, Fallon NC, Rehman A,
Pylayeva-Gupta Y, et al: MyD88 inhibition amplifies dendritic cell
capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp
Med. 209:1671–1687. 2012.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Michaud DS, Joshipura K, Giovannucci E and
Fuchs CS: A prospective study of periodontal disease and pancreatic
cancer in US male health professionals. J Natl Cancer Inst.
99:171–175. 2007.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Farrell JJ, Zhang L, Zhou H, Chia D,
Elashoff D, Akin D, Paster BJ, Joshipura K and Wong DT: Variations
of oral microbiota are associated with pancreatic diseases
including pancreatic cancer. Gut. 61:582–588. 2012.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Wiest R and Garcia-Tsao G: Bacterial
translocation (BT) in cirrhosis. Hepatology. 41:422–433.
2005.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Seki E, De Minicis S, Osterreicher CH,
Kluwe J, Osawa Y, Brenner DA and Schwabe RF: TLR4 enhances TGF-beta
signaling and hepatic fibrosis. Nat Med. 13:1324–1332.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
160
|
Yu LX, Yan HX, Liu Q, Yang W, Wu HP, Dong
W, Tang L, Lin Y, He YQ, Zou SS, et al: Endotoxin accumulation
prevents carcinogen-induced apoptosis and promotes liver
tumorigenesis in rodents. Hepatology. 52:1322–1333. 2010.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Xuan C, Shamonki JM, Chung A, Dinome ML,
Chung M, Sieling PA and Lee DJ: Microbial dysbiosis is associated
with human breast cancer. PLoS One. 9(e83744)2014.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Velicer CM, Heckbert SR, Lampe JW, Potter
JD, Robertson CA and Taplin SH: Antibiotic use in relation to the
risk of breast cancer. JAMA. 291:827–835. 2004.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Wu S, Powell J, Mathioudakis N, Kane S,
Fernandez E and Sears CL: Bacteroides fragilis enterotoxin induces
intestinal epithelial cell secretion of interleukin-8 through
mitogen-activated protein kinases and a tyrosine kinase-regulated
nuclear factor-kappaB pathway. Infect Immun. 72:5832–5839.
2004.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Nougayrède JP, Taieb F, De Rycke J and
Oswald E: Cyclomodulins: Bacterial effectors that modulate the
eukaryotic cell cycle. Trends Microbiol. 13:103–110.
2005.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Nesić D, Hsu Y and Stebbins CE: Assembly
and function of a bacterial genotoxin. Nature. 429:429–433.
2004.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Oswald E, Nougayrède JP, Taieb F and Sugai
M: Bacterial toxins that modulate host cell-cycle progression. Curr
Opin Microbiol. 8:83–91. 2005.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Travaglione S, Fabbri A and Fiorentini C:
The Rho-activating CNF1 toxin from pathogenic E. coli: A risk
factor for human cancer development? Infect Agent Cancer.
3(4)2008.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Fox JG and Wang TC: Inflammation, atrophy,
and gastric cancer. J Clin Invest. 117:60–69. 2007.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Ohnishi N, Yuasa H, Tanaka S, Sawa H,
Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, et
al: Transgenic expression of Helicobacter pylori CagA induces
gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl
Acad Sci USA. 105:1003–1008. 2008.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Sears CL: Enterotoxigenic Bacteroides
fragilis: A rogue among symbiotes. Clin Microbiol Rev. 22:349–369.
2009.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Wu S, Lim KC, Huang J, Saidi RF and Sears
CL: Bacteroides fragilis enterotoxin cleaves the zonula adherens
protein, E-cadherin. Proc Natl Acad Sci USA. 95:14979–14984.
1998.PubMed/NCBI
|
|
172
|
Wu S, Shin J, Zhang G, Cohen M, Franco A
and Sears CL: The Bacteroides fragilis toxin binds to a specific
intestinal epithelial cell receptor. Infect Immun. 74:5382–5390.
2006.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Toprak NU, Yagci A, Gulluoglu BM, Akin ML,
Demirkalem P, Celenk T and Soyletir G: A possible role of
Bacteroides fragilis enterotoxin in the aetiology of colorectal
cancer. Clin Microbiol Infect. 12:782–786. 2006.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Wu S, Morin PJ, Maouyo D and Sears CL:
Bacteroides fragilis enterotoxin induces c-Myc expression and
cellular proliferation. Gastroenterology. 124:392–400.
2003.PubMed/NCBI View Article : Google Scholar
|
|
175
|
Owen RW, Spiegelhalder B and Bartsch H:
Generation of reactive oxygen species by the faecal matrix. Gut.
46:225–232. 2000.PubMed/NCBI View Article : Google Scholar
|
|
176
|
Huycke MM, Abrams V and Moore DR:
Enterococcus faecalis produces extracellular superoxide and
hydrogen peroxide that damages colonic epithelial cell DNA.
Carcinogenesis. 23:529–536. 2002.PubMed/NCBI
|
|
177
|
Wallace JL: Hydrogen sulfide-releasing
anti-inflammatory drugs. Trends Pharmacol Sci. 28:501–505.
2007.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Attene-Ramos MS, Wagner ED, Gaskins HR and
Plewa MJ: Hydrogen sulfide induces direct radical-associated DNA
damage. Mol Cancer Res. 5:455–459. 2007.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Le Gall T, Clermont O, Gouriou S, Picard
B, Nassif X, Denamur E and Tenaillon O: Extraintestinal virulence
is a coincidental by-product of commensalism in B2 phylogenetic
group Escherichia coli strains. Mol Biol Evol. 24:2373–2384.
2007.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Escobar-Páramo P, Grenet K, Le Menac'h A,
Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC,
Andremont A, et al: Large-scale population structure of human
commensal Escherichia coli isolates. Appl Environ Microbiol.
70:5698–5700. 2004.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Darfeuille-Michaud A, Boudeau J, Bulois P,
Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie
L and Colombel JF: High prevalence of adherent-invasive Escherichia
coli associated with ileal mucosa in Crohn's disease.
Gastroenterology. 127:412–421. 2004.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Han YW, Ikegami A, Rajanna C, Kawsar HI,
Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK and Deng CX:
Identification and characterization of a novel adhesin unique to
oral fusobacteria. J Bacteriol. 187:5330–5340. 2005.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Prorok-Hamon M, Friswell MK, Alswied A,
Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR,
Winstanley C, et al: Colonic mucosa-associated diffusely adherent
afaC+ Escherichia coli expressing lpfA and pks are increased in
inflammatory bowel disease and colon cancer. Gut. 63:761–770.
2014.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Morrison DJ and Preston T: Formation of
short chain fatty acids by the gut microbiota and their impact on
human metabolism. Gut Microbes. 7:189–200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
185
|
Belcheva A, Irrazabal T, Robertson SJ,
Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK,
Surendra A, Kumar S, et al: Gut microbial metabolism drives
transformation of MSH2-deficient colon epithelial cells. Cell.
158:288–299. 2014.PubMed/NCBI View Article : Google Scholar
|
|
186
|
LeBlanc JG, Milani C, de Giori GS, Sesma
F, van Sinderen D and Ventura M: Bacteria as vitamin suppliers to
their host: A gut microbiota perspective. Curr Opin Biotechnol.
24:160–168. 2013.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Russell WR, Gratz SW, Duncan SH, Holtrop
G, Ince J, Scobbie L, Duncan G, Johnstone AM, Lobley GE, Wallace
RJ, et al: High-protein, reduced-carbohydrate weight-loss diets
promote metabolite profiles likely to be detrimental to colonic
health. Am J Clin Nutr. 93:1062–1072. 2011.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Windey K, De Preter V and Verbeke K:
Relevance of protein fermentation to gut health. Mol Nutr Food Res.
56:184–196. 2012.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Neis EP, Dejong CH and Rensen SS: The role
of microbial amino acid metabolism in host metabolism. Nutrients.
7:2930–2946. 2015.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Verbeke KA, Boobis AR, Chiodini A, Edwards
CA, Franck A, Kleerebezem M, Nauta A, Raes J, van Tol EA and Tuohy
KM: Towards microbial fermentation metabolites as markers for
health benefits of prebiotics. Nutr Res Rev. 28:42–66.
2015.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Louis P, Hold GL and Flint HJ: The gut
microbiota, bacterial metabolites and colorectal cancer. Nat Rev
Microbiol. 12:661–672. 2014.PubMed/NCBI View Article : Google Scholar
|
|
192
|
Donohoe DR, Garge N, Zhang X, Sun W,
O'Connell TM, Bunger MK and Bultman SJ: The microbiome and butyrate
regulate energy metabolism and autophagy in the mammalian colon.
Cell Metab. 13:517–526. 2011.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Roediger WE: Role of anaerobic bacteria in
the metabolic welfare of the colonic mucosa in man. Gut.
21:793–798. 1980.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Roediger WE: Utilization of nutrients by
isolated epithelial cells of the rat colon. Gastroenterology.
83:424–429. 1982.PubMed/NCBI
|
|
195
|
Sleeth ML, Thompson EL, Ford HE,
Zac-Varghese SE and Frost G: Free fatty acid receptor 2 and
nutrient sensing: A proposed role for fibre, fermentable
carbohydrates and short-chain fatty acids in appetite regulation.
Nutr Res Rev. 23:135–145. 2010.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Pessione E: Lactic acid bacteria
contribution to gut microbiota complexity: Lights shadows. Front
Cell Infect Microbiol. 2(86)2012.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Hamer HM, Jonkers D, Venema K, Vanhoutvin
S, Troost FJ and Brummer RJ: Review article: The role of butyrate
on colonic function. Aliment Pharmacol Ther. 27:104–119.
2008.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Fung KYC, Cosgrove L, Lockett T, Head R
and Topping DL: A review of the potential mechanisms for the
lowering of colorectal oncogenesis by butyrate. Br J Nutr.
108:820–831. 2012.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Wilson AJ, Chueh AC, Tögel L, Corner GA,
Ahmed N, Goel S, Byun DS, Nasser S, Houston MA, Jhawer M, et al:
Apoptotic sensitivity of colon cancer cells to histone deacetylase
inhibitors is mediated by an Sp1/Sp3-activated transcriptional
program involving immediate-early gene induction. Cancer Res.
70:609–620. 2010.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Chang PV, Hao L, Offermanns S and
Medzhitov R: The microbial metabolite butyrate regulates intestinal
macrophage function via histone deacetylase inhibition. Proc Natl
Acad Sci USA. 111:2247–2252. 2014.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Smith PM, Howitt MR, Panikov N, Michaud M,
Gallini CA, Bohlooly YM, Glickman JN and Garrett WS: The microbial
metabolites, short-chain fatty acids, regulate colonic Treg cell
homeostasis. Science. 341:569–573. 2013.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Furusawa Y, Obata Y, Fukuda S, Endo TA,
Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et
al: Commensal microbe-derived butyrate induces the differentiation
of colonic regulatory T cells. Nature. 504:446–450. 2013.PubMed/NCBI View Article : Google Scholar
|
|
203
|
Arpaia N, Campbell C, Fan X, Dikiy S, van
der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et
al: Metabolites produced by commensal bacteria promote peripheral
regulatory T-cell generation. Nature. 504:451–455. 2013.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Donohoe DR, Holley D, Collins LB,
Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW,
Greenwalt A, Ryan EP, et al: A gnotobiotic mouse model demonstrates
that dietary fiber protects against colorectal tumorigenesis in a
microbiota- and butyrate-dependent manner. Cancer Discov.
4:1387–1397. 2014.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Donohoe DR, Collins LB, Wali A, Bigler R,
Sun W and Bultman SJ: The Warburg effect dictates the mechanism of
butyrate-mediated histone acetylation and cell proliferation. Mol
Cell. 48:612–626. 2012.PubMed/NCBI View Article : Google Scholar
|
|
207
|
Sebastián C and Mostoslavsky R: Untangling
the fiber yarn: Butyrate feeds Warburg to suppress colorectal
cancer. Cancer Discov. 4:1368–1370. 2014.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Davie JR: Inhibition of histone
deacetylase activity by butyrate. J Nutr. 133((Suppl 7)):
2485S–2493S. 2003.PubMed/NCBI View Article : Google Scholar
|
|
209
|
Gonçalves P and Martel F: Butyrate and
colorectal cancer: The role of butyrate transport. Curr Drug Metab.
14:994–1008. 2013.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Thangaraju M, Cresci GA, Liu K, Ananth S,
Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ,
Lambert NA, et al: GPR109A is a G-protein-coupled receptor for the
bacterial fermentation product butyrate and functions as a tumor
suppressor in colon. Cancer Res. 69:2826–2832. 2009.PubMed/NCBI View Article : Google Scholar
|
|
211
|
Singh N, Gurav A, Sivaprakasam S, Brady E,
Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, et
al: Activation of Gpr109a, receptor for niacin and the commensal
metabolite butyrate, suppresses colonic inflammation and
carcinogenesis. Immunity. 40:128–139. 2014.PubMed/NCBI View Article : Google Scholar
|
|
212
|
Larrosa M, González-Sarrías A,
García-Conesa MT, Tomás-Barberán FA and Espín JC: Urolithins,
ellagic acid-derived metabolites produced by human colonic
microflora, exhibit estrogenic and antiestrogenic activities. J
Agric Food Chem. 54:1611–1620. 2006.PubMed/NCBI View Article : Google Scholar
|
|
213
|
González-Sarrías A, Larrosa M,
Tomás-Barberán FA, Dolara P and Espín JC: NF-kappaB-dependent
anti-inflammatory activity of urolithins, gut microbiota ellagic
acid-derived metabolites, in human colonic fibroblasts. Br J Nutr.
104:503–512. 2010.PubMed/NCBI View Article : Google Scholar
|
|
214
|
Atkinson C, Frankenfeld CL and Lampe JW:
Gut bacterial metabolism of the soy isoflavone daidzein: Exploring
the relevance to human health. Exp Biol Med (Maywood). 230:155–170.
2005.PubMed/NCBI
|
|
215
|
Bolca S, Possemiers S, Herregat A,
Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De
Keukeleire D, Bracke M, et al: Microbial and dietary factors are
associated with the equol producer phenotype in healthy
postmenopausal women. J Nutr. 137:2242–2246. 2007.PubMed/NCBI View Article : Google Scholar
|
|
216
|
Lampe JW: Emerging research on equol
cancer. J Nutr. 140:1369S–1372S. 2010.PubMed/NCBI View Article : Google Scholar
|
|
217
|
Davis CD and Milner JA: Gastrointestinal
microflora, food components and colon cancer prevention. J Nutr
Biochem. 20:743–752. 2009.PubMed/NCBI View Article : Google Scholar
|
|
218
|
Bode LM, Bunzel D, Huch M, Cho GS, Ruhland
D, Bunzel M, Bub A, Franz CM and Kulling SE: In vivo and in vitro
metabolism of trans-resveratrol by human gut microbiota. Am J Clin
Nutr. 97:295–309. 2013.PubMed/NCBI View Article : Google Scholar
|
|
219
|
Greer JB and O'Keefe SJ: Microbial
induction of immunity, inflammation, and cancer. Front Physiol.
1(168)2011.PubMed/NCBI View Article : Google Scholar
|
|
220
|
Ridlon JM, Kang DJ and Hylemon PB: Bile
salt biotransformations by human intestinal bacteria. J Lipid Res.
47:241–259. 2006.PubMed/NCBI View Article : Google Scholar
|
|
221
|
Wells JE, Williams KB, Whitehead TR,
Heuman DM and Hylemon PB: Development and application of a
polymerase chain reaction assay for the detection and enumeration
of bile acid 7alpha-dehydroxylating bacteria in human feces. Clin
Chim Acta. 331:127–134. 2003.PubMed/NCBI View Article : Google Scholar
|
|
222
|
Rubin DC, Shaker A and Levin MS: Chronic
intestinal inflammation: Inflammatory bowel disease and
colitis-associated colon cancer. Front Immunol.
3(107)2012.PubMed/NCBI View Article : Google Scholar
|
|
223
|
Powolny A, Xu J and Loo G: Deoxycholate
induces DNA damage and apoptosis in human colon epithelial cells
expressing either mutant or wild-type p53. Int J Biochem Cell Biol.
33:193–203. 2001.PubMed/NCBI View Article : Google Scholar
|
|
224
|
Imray CH, Radley S, Davis A, Barker G,
Hendrickse CW, Donovan IA, Lawson AM, Baker PR and Neoptolemos JP:
Faecal unconjugated bile acids in patients with colorectal cancer
or polyps. Gut. 33:1239–1245. 1992.PubMed/NCBI View Article : Google Scholar
|
|
225
|
Nagengast FM, Grubben MJ and van Munster
IP: Role of bile acids in colorectal carcinogenesis. Eur J Cancer.
31A:1067–1070. 1995.PubMed/NCBI View Article : Google Scholar
|
|
226
|
Carmody RN and Turnbaugh PJ:
Host-microbial interactions in the metabolism of therapeutic and
diet-derived xenobiotics. J Clin Invest. 124:4173–4181.
2014.PubMed/NCBI View Article : Google Scholar
|
|
227
|
Flanagan L, Schmid J, Ebert M, Soucek P,
Kunicka T, Liska V, Bruha J, Neary P, Dezeeuw N, Tommasino M, et
al: Fusobacterium nucleatum associates with stages of colorectal
neoplasia development, colorectal cancer and disease outcome. Eur J
Clin Microbiol Infect Dis. 33:1381–1390. 2014.PubMed/NCBI View Article : Google Scholar
|
|
228
|
McCoy AN, Araújo-Pérez F, Azcárate-Peril
A, Yeh JJ, Sandler RS and Keku TO: Fusobacterium is associated with
colorectal adenomas. PLoS One. 8(e53653)2013.PubMed/NCBI View Article : Google Scholar
|
|
229
|
Fukugaiti MH, Ignacio A, Fernandes MR,
Ribeiro Júnior U, Nakano V and Avila-Campos MJ: High occurrence of
Fusobacterium nucleatum and Clostridium difficile in the intestinal
microbiota of colorectal carcinoma patients. Braz J Microbiol.
46:1135–1140. 2015.PubMed/NCBI View Article : Google Scholar
|
|
230
|
Zackular JP, Rogers MAM, Ruffin MT IV and
Schloss PD: The human gut microbiome as a screening tool for
colorectal cancer. Cancer Prev Res (Phila). 7:1112–1121.
2014.PubMed/NCBI View Article : Google Scholar
|
|
231
|
Mima K, Nishihara R, Qian ZR, Cao Y,
Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al:
Fusobacterium nucleatum in colorectal carcinoma tissue and patient
prognosis. Gut. 65:1973–1980. 2016.PubMed/NCBI View Article : Google Scholar
|
|
232
|
Ballal SA, Veiga P, Fenn K, Michaud M, Kim
JH, Gallini CA, Glickman JN, Quéré G, Garault P, Béal C, et al:
Host lysozyme-mediated lysis of Lactococcus lactis facilitates
delivery of colitis-attenuating superoxide dismutase to inflamed
colons. Proc Natl Acad Sci USA. 112:7803–7808. 2015.PubMed/NCBI View Article : Google Scholar
|
|
233
|
Veiga P, Gallini CA, Beal C, Michaud M,
Delaney ML, DuBois A, Khlebnikov A, van Hylckama Vlieg JE, Punit S,
Glickman JN, et al: Bifidobacterium animalis subsplactis fermented
milk product reduces inflammation by altering a niche for
colitogenic microbes. Proc Natl Acad Sci USA. 107:18132–18137.
2010.PubMed/NCBI View Article : Google Scholar
|
|
234
|
Viaud S, Saccheri F, Mignot G, Yamazaki T,
Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ,
et al: The intestinal microbiota modulates the anticancer immune
effects of cyclophosphamide. Science. 342:971–976. 2013.PubMed/NCBI View Article : Google Scholar
|
|
235
|
Siddik ZH: Cisplatin: Mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003.PubMed/NCBI View Article : Google Scholar
|
|
236
|
Yang J, Liu KX, Qu JM and Wang XD: The
changes induced by cyclophosphamide in intestinal barrier and
microflora in mice. Eur J Pharmacol. 714:120–124. 2013.PubMed/NCBI View Article : Google Scholar
|
|
237
|
Nam YD, Kim HJ, Seo JG, Kang SW and Bae
JW: Impact of pelvic radiotherapy on gut microbiota of
gynecological cancer patients revealed by massive pyrosequencing.
PLoS One. 8(e82659)2013.PubMed/NCBI View Article : Google Scholar
|
|
238
|
Jenq RR, Ubeda C, Taur Y, Menezes CC,
Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, et al:
Regulation of intestinal inflammation by microbiota following
allogeneic bone marrow transplantation. J Exp Med. 209:903–911.
2012.PubMed/NCBI View Article : Google Scholar
|
|
239
|
Von Bültzingslöwen I, Adlerberth I, Wold
AE, Dahlén G and Jontell M: Oral and intestinal microflora in
5-fluorouracil treated rats, translocation to cervical and
mesenteric lymph nodes and effects of probiotic bacteria. Oral
Microbiol Immunol. 18:278–284. 2003.PubMed/NCBI View Article : Google Scholar
|
|
240
|
Wallace BD, Wang H, Lane KT, Scott JE,
Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, et al:
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.
Science. 330:831–835. 2010.PubMed/NCBI View Article : Google Scholar
|
|
241
|
Lam W, Bussom S, Guan F, Jiang Z, Zhang W,
Gullen EA, Liu SH and Cheng YC: The four-herb Chinese medicine
PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci
Transl Med. 2(45ra59)2010.PubMed/NCBI View Article : Google Scholar
|
|
242
|
Cesaro C, Tiso A, Del Prete A, Cariello R,
Tuccillo C, Cotticelli G, Del Vecchio Blanco C and Loguercio C: Gut
microbiota and probiotics in chronic liver diseases. Dig Liver Dis.
43:431–438. 2011.PubMed/NCBI View Article : Google Scholar
|
|
243
|
Hemarajata P and Versalovic J: Effects of
probiotics on gut microbiota: Mechanisms of intestinal
immunomodulation and neuromodulation. Therap Adv Gastroenterol.
6:39–51. 2013.PubMed/NCBI View Article : Google Scholar
|
|
244
|
Ekmekciu I, von Klitzing E, Fiebiger U,
Neumann C, Bacher P, Scheffold A, Bereswill S and Heimesaat MM: The
probiotic compound VSL#3 modulates mucosal, peripheral, and
systemic immunity following murine broad-spectrum antibiotic
treatment. Front Cell Infect Microbiol. 7(167)2017.PubMed/NCBI View Article : Google Scholar
|
|
245
|
Rao RK and Samak G: Protection and
restitution of gut barrier by probiotics Nutritional and clinical
implications. Curr Nutr Food Sci. 9:99–107. 2013.PubMed/NCBI
|
|
246
|
Kamada N, Chen GY, Inohara N and Núñez G:
Control of pathogens and pathobionts by the gut microbiota. Nat
Immunol. 14:685–690. 2013.PubMed/NCBI View Article : Google Scholar
|
|
247
|
Jonkers D and Stockbrügger R: Probiotics
and inflammatory bowel disease. J R Soc Med. 96:167–171.
2003.PubMed/NCBI
|
|
248
|
Celiberto LS, Bedani R, Rossi EA and
Cavallini DC: Probiotics: The scientific evidence in the context of
inflammatory bowel disease. Crit Rev Food Sci Nutr. 57:1759–1768.
2017.PubMed/NCBI View Article : Google Scholar
|
|
249
|
Sheil B, Shanahan F and O'Mahony L:
Probiotic effects on inflammatory bowel disease. J Nutr. 137:(Suppl
2):819S–824S. 2007.PubMed/NCBI View Article : Google Scholar
|
|
250
|
Tamboli CP, Caucheteux C, Cortot A,
Colombel JF and Desreumaux P: Probiotics in inflammatory bowel
disease: A critical review. Best Pract Res Clin Gastroenterol.
17:805–820. 2003.PubMed/NCBI View Article : Google Scholar
|
|
251
|
Bibiloni R, Fedorak RN, Tannock GW, Madsen
KL, Gionchetti P, Campieri M, De Simone C and Sartor RB: VSL#3
probiotic-mixture induces remission in patients with active
ulcerative colitis. Am J Gastroenterol. 100:1539–1546.
2005.PubMed/NCBI View Article : Google Scholar
|
|
252
|
Kim S, Covington A and Pamer EG: The
intestinal microbiota: Antibiotics, colonization resistance, and
enteric pathogens. Immunol Rev. 279:90–105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
253
|
Dethlefsen L, Huse S, Sogin ML and Relman
DA: The pervasive effects of an antibiotic on the human gut
microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol.
6(e280)2008.PubMed/NCBI View Article : Google Scholar
|
|
254
|
Dethlefsen L and Relman DA: Incomplete
recovery and individualized responses of the human distal gut
microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci
USA. 108((Suppl 1)): 4554–4561. 2011.PubMed/NCBI View Article : Google Scholar
|
|
255
|
Jernberg C, Löfmark S, Edlund C and
Jansson JK: Long-term ecological impacts of antibiotic
administration on the human intestinal microbiota. ISME J. 1:56–66.
2007.PubMed/NCBI View Article : Google Scholar
|
|
256
|
Lankelma JM, Cranendonk DR, Belzer C, de
Vos AF, de Vos WM, van der Poll T and Wiersinga WJ:
Antibiotic-induced gut microbiota disruption during human
endotoxemia: A randomised controlled study. Gut. 66:1623–1630.
2017.PubMed/NCBI View Article : Google Scholar
|
|
257
|
Lopez J and Grinspan A: Fecal microbiota
transplantation for inflammatory bowel disease. Gastroenterol
Hepatol (NY). 12:374–379. 2016.PubMed/NCBI
|
|
258
|
McFarland LV: Epidemiology, risk factors
and treatments for antibiotic-associated diarrhea. Dig Dis.
16:292–307. 1998.PubMed/NCBI View Article : Google Scholar
|
|
259
|
Suez J, Zmora N, Zilberman-Schapira G, Mor
U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev
Brik R, Federici S, et al: Post-antibiotic gut mucosal microbiome
reconstitution is impaired by probiotics and improved by autologous
FMT. Cell. 174:1406–1423, e16. 2018.PubMed/NCBI View Article : Google Scholar
|
|
260
|
Chaput N, Lepage P, Coutzac C, Soularue E,
Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, et
al: Baseline gut microbiota predicts clinical response and colitis
in metastatic melanoma patients treated with ipilimumab. Ann Oncol.
28:1368–1379. 2017.PubMed/NCBI View Article : Google Scholar
|
|
261
|
Frankel AE, Coughlin LA, Kim J, Froehlich
TW, Xie Y, Frenkel EP and Koh AY: Metagenomic shotgun sequencing
and unbiased metabolomic profiling identify specific human gut
microbiota and metabolites associated with immune checkpoint
therapy efficacy in melanoma patients. Neoplasia. 19:848–855.
2017.PubMed/NCBI View Article : Google Scholar
|
|
262
|
Gopalakrishnan V, Spencer CN, Nezi L,
Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman
K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science. 359:97–103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
263
|
Matson V, Fessler J, Bao R, Chongsuwat T,
Zha Y, Alegre ML, Luke JJ and Gajewski TF: The commensal microbiome
is associated with anti-PD-1 efficacy in metastatic melanoma
patients. Science. 359:104–108. 2018.PubMed/NCBI View Article : Google Scholar
|
|
264
|
Routy B, Le Chatelier E, Derosa L, Duong
CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C,
Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based
immunotherapy against epithelial tumors. Science. 359:91–97.
2018.PubMed/NCBI View Article : Google Scholar
|
|
265
|
Vétizou M, Pitt JM, Daillère R, Lepage P,
Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong
CP, et al: Anticancer immunotherapy by CTLA-4 blockade relies on
the gut microbiota. Science. 350:1079–1084. 2015.PubMed/NCBI View Article : Google Scholar
|
|
266
|
Sivan A, Corrales L, Hubert N, Williams
JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B,
Alegre ML, et al: Commensal Bifidobacterium promotes antitumor
immunity and facilitates anti-PD-L1 efficacy. Science.
350:1084–1089. 2015.PubMed/NCBI View Article : Google Scholar
|
